Echinacoside inhibits ferroptosis and pyroptosis in ARDS through modulation of the KEAP1/NRF2/P62 signaling pathway
International Immunopharmacology · 2026-12 · 191 · 117631
DOI: 10.1016/j.intimp.2026.117631 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026-12. Verfasst von Dan Su und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China; Department of Cardiology, the Second…. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Acute respiratory distress syndrome (ARDS) remains a life-threatening pulmonary condition with persistently high mortality rates. Echinacoside (ECH) is a natural compound that has shown protective effects in experimental acute lung injury; however, the molecular mechanisms underlying its effects in ARDS remain incompletely understood. This study aimed to explore the potential mechanisms underlying the protective role of ECH in ARDS. METHODS: The protective effect of ECH on ARDS mice was evaluated. Subsequently, network pharmacology combined with RNA-sequencing was employed to identify mechanisms modulated by ECH. Finally, the mechanism of ECH on ARDS was verified in ARDS mice and mouse lung epithelial cells. RESULTS: ECH reduced the level of inflammatory response and alleviated lung injury in ARDS mice. Network pharmacology and RNA sequencing results suggested that its mechanism may be related to regulating inflammatory response, anti-oxidative stress, and inhibiting cell death. Further experiments indicated that ECH inhibited ferroptosis and pyroptosis, possibly through regulation of the KEAP1/NRF2 axis. Molecular dynamics, molecular docking, and protein-small molecule interaction verification demonstrated that ECH binds to the Kelch/DGR domain of KEAP1. CONCLUSIONS: ECH binds to KEAP1 and may interfere with the KEAP1-NRF2 interaction, thereby promoting NRF2 release, which subsequently suppresses cellular pyroptosis and ferroptosis, ultimately reducing inflammation and lung injury. These findings support further investigation of ECH as a potential strategy for ARDS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Critical Care Medicine, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China; Department of Cardiology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Department of Critical Care Medicine, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Department of Critical Care Medicine, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Electronic address: gang_wang@xjtu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Su, D., Li, R., Deng, G., Li, J., Ren, J., Gao, Y., Zhang, J., Han, Z., Deng, J., Song, A., & Wang, G. (2026). Echinacoside inhibits ferroptosis and pyroptosis in ARDS through modulation of the KEAP1/NRF2/P62 signaling pathway. International Immunopharmacology, 191, 117631. https://doi.org/10.1016/j.intimp.2026.117631
Vancouver
Su D, Li R, Deng G, Li J, Ren J, Gao Y, et al. Echinacoside inhibits ferroptosis and pyroptosis in ARDS through modulation of the KEAP1/NRF2/P62 signaling pathway. International Immunopharmacology. 2026;191:117631. doi:10.1016/j.intimp.2026.117631
BibTeX
@article{Su2026,
author = {Su, Dan and Li, Ruohan and Deng, Guorong and Li, Jiamei and Ren, Jiajia and Gao, Ya and Zhang, Jingjing and Han, Zhenhua and Deng, Jie and Song, Anqi and Wang, Gang},
title = {Echinacoside inhibits ferroptosis and pyroptosis in ARDS through modulation of the KEAP1/NRF2/P62 signaling pathway},
journal = {International Immunopharmacology},
year = {2026},
volume = {191},
pages = {117631},
doi = {10.1016/j.intimp.2026.117631}
}
EUVIMED